M BEATRIZ
LLAMUSI TROISI
INVEST DOCT UV SENIOR
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2021
-
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
Molecular Therapy - Nucleic Acids, Vol. 26, pp. 174-191
-
Rabphilin silencing causes dilated cardiomyopathy in a Drosophila model of nephrocyte damage
Scientific Reports, Vol. 11, Núm. 1
2015
-
Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model
DMM Disease Models and Mechanisms, Vol. 8, Núm. 7, pp. 679-690